-
admin
Posts
QATAR TO CREATE A PERMANENT NATIONAL PAVILION IN THE GIARDINI OF VENICE, HISTORIC VENUE OF LA BIENNALE DI VENEZIA
The Qatar Pavilion at the 19th International Architecture Exhibition – La Biennale di Venezia to Feature Two-Part Exhibition Organised by Qatar’s Future Art Mill Museum, with...
Quantinuum’s “Reimei” Quantum Computer Now Fully Operational at RIKEN, Ushering in a New Era of Hybrid Quantum High-Performance Computing
Quantinuum’s “Reimei” quantum computer installed at RIKEN‘s world-class facility will accelerate scientific progress of quantum computing across physics, chemistry, and other applications TOKYO, Feb. 12, 2025 /PRNewswire/ —...
Bread Financial Provides Performance Update for January 2025
COLUMBUS, Ohio, Feb. 11, 2025 (GLOBE NEWSWIRE) — Bread Financial® Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and...
Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance
Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a...
Arvinas Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
– Announced that topline data from the monotherapy Phase 3 VERITAC-2 trial is anticipated in 1Q25 – – Presented Phase 1b data from the TACTIVE-U...
Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus
LP-310 Treatment Demonstrates Clinically Meaningful Reductions in Pain, Ulceration, and Inflammation Across All Key Metrics Findings Highlight Favorable Safety Profile and Tolerability of Twice-Daily Oral...
Yaqrit prepares phase 3 for ammonia scavenger in hepatic encephalopathy
Acute and chronic treatment for hepatic encephalopathy acquired from Mallinckrodt Pharmaceuticals in September 2024 Extended pre-clinical, clinical and IP package includes FDA and EMA orphan...
Bind Research launched to transform disordered proteins into effective drug targets
Bind Research launched to transform disordered proteins into effective drug targets UK’s first not-for-profit Focused Research Organisation supported by Department for Science, Research and Innovation’s...
Roquette Reshapes the Pharmaceutical Coating Landscape with an Innovative and High-Performance Platform
Roquette Reshapes the Pharmaceutical Coating Landscape with an Innovative and High-Performance Platform Lille – 11 February 2025 – Roquette launches a new coatings platform, combining...
GMCC & Welling Showcase at AHR Expo 2025 with Tailored Portfolio for the North American Market
ORLANDO, Fla., Feb. 11, 2025 /PRNewswire/ — GMCC & Welling, the global leading integrated core component solution provider of HVACR showcased a series of products...
